Brief: CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing Facility
09/03/2026 15:00
March 9 (Reuters) - CSL Ltd CSL.AX: CSL: ANNOUNCES EXPANSION OF ILLINOIS PLASMA THERAPY MANUFACTURING FACILITY CSL: KANKAKEE ILLINOIS FACILITY EXPANSION, EXPECTED TO BE OPERATIONAL BY 2031 CSL: EXPANSION WILL CREATE AT LEAST 300 NEW PHARMACEUTICAL ROLES Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsAustralia's CSL faces investor proceeding over disclosure obligations (updated)
Australia's CSL faces investor proceeding over disclosure obligations
Citi says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)
Brief: CSL Limited Appoints Deborah Waterhouse As CEO And Managing Director